COVID-19 Clinical Trials in Los Angeles

Showing 61-80 of 168 trials

Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake

NCT05586178

This study investigates different ways to elevate intentions to get the COVID-19 booster via text-based reminders, including providing information about the booster and leveraging the consistency principle. The proposed randomized controlled trial will examine the impact of these reminders on booster uptake.

COVID-19Vaccines

University of California, Los Angeles177,720 participantsStarted Oct 2022

Los Angeles, California, United States

COMPLETEDNA< 1 mile

Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities

NCT04901624

Repeat testing for SARS-CoV-2 antibodies in disadvantaged communities will help identify active and recovered infections over time, and as more is understood about antibody protection, it may help identify persons who have immunity. Many questions about social barriers and behavioral facilitators remain unanswered. This project aims to evaluate the effectiveness of risk-based messaging and incentives that promote repeated testing for SARS-CoV-2 antibodies, as well as to understand social and behavioral determinants of COVID-19 testing and variations within sub-groups of this population.

SARS-CoV-2

University of Southern California2,164 participantsStarted Jun 2021

Los Angeles, California, United States

Information Provision and Consistency Framing to Increase COVID-19 Booster Uptake

Use of Behavioral Economics in Repeat SARS-CoV-2 (COVID-19) Antibody Testing in Disadvantaged Communities

COVID-19 Trials in Other Cities

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

Post COVID-19 Vaccination Analysis in Healthcare Worker Recipients

Evaluating the Response of the Immune System of People with Long COVID (post SARS-CoV-2)

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

IMM-BCP-01 in Mild to Moderate COVID-19

Neuromodulation With Percutaneous Electrical Nerve Field Stimulation for Adults With COVID-19

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19

The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19

PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients

A 2nd Generation E1/E2B/E3-Deleted Adenoviral COVID-19 Vaccine: The TCELL VACCINE TRIAL

Developing and Testing a COVID-19 Vaccination Acceptance Intervention

Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Other Conditions in Los Angeles